Antibiotic prophylaxis in antenatal nonrefluxing hydronephrosis, megaureter and ureterocele

Area of Science:

• Pediatric Urology
• Nephrology
• Infectious Disease

Background:

• Observation is a management option for infants with antenatally detected hydronephrosis, primary nonrefluxing megaureter, and ureterocele.
• Urinary tract infection (UTI) risk is a concern in these infants, prompting consideration of antibiotic prophylaxis.
• Evidence on the efficacy of prophylactic antibiotics in this specific population is limited, with variable clinical practices.

Purpose of the Study:

• To evaluate the necessity and efficacy of antibiotic prophylaxis in infants diagnosed with specific urinary tract anomalies.
• To identify risk factors for UTI in infants with hydronephrosis, megaureter, and ureterocele.
• To guide clinical practice regarding antibiotic prophylaxis in pediatric urology.

Main Methods:

• Review of existing literature and clinical data on infants with nonrefluxing hydronephrosis, primary nonrefluxing megaureter, and ureterocele.
• Analysis of UTI rates in patients managed with and without antibiotic prophylaxis.
• Risk stratification based on hydronephrosis grade, ureteral dilatation, and presence of ureterocele.

Main Results:

• Antibiotic prophylaxis appears unnecessary for isolated low-grade hydronephrosis.
• Infants with high-grade nonrefluxing hydronephrosis, particularly with hydroureteronephrosis, face an increased UTI risk.
• Risk is highest in the first 6 months of life, especially with catheterization during workup.

Conclusions:

• Prophylactic antibiotics may be prudent for infants with high-grade hydronephrosis and hydroureteronephrosis (with or without ureterocele) during the first 6-12 months, especially before diagnostic workup completion.
• Further controlled trials are needed to definitively compare outcomes with and without antibiotic prophylaxis.
• Clinical decisions should consider individual risk factors and the specific diagnosis.